Unable to load price data. Sorry.

¯\_(ツ)_/¯

Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: No stars

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NYSE:MRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

204 Outperform
15 Underperform
 

All-Star Players

33 Outperform
5 Underperform
 

Wall Street

11 Outperform
1 Underperform
 

Top NYSE:MRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Richthofen80 (86.91)
Submitted June 22, 2008

Pure speculation on the Liposonix acquisition. Surgery free fat removal has huge potential if FDA approves. If not, at least they get international exposure because the process is already approved in Europe.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NYSE:MRX VS S&P 500 (SPY)

Fools bullish on NYSE:MRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about MRX.

Recs

0
Member Avatar pbk100 (29.33) Submitted: 6/8/2011 12:01:45 PM : Outperform Start Price: $36.03 NYSE:MRX Score: -98.62

Magic Formula + Insider buying

Recs

0
Member Avatar coryjobe (93.26) Submitted: 7/24/2010 4:53:24 PM : Outperform Start Price: $23.30 NYSE:MRX Score: -77.14

Due to high demand of Triaz, Ziana, and Solodyn sales have been up and should continue to keep going up. They also have a strong group of products to help reduce acne. Medics continue to spend a lot of time and money to develop new products and improve their already strong list of products, this should help them keep increasing their earnings in the future. They currently have a great balance sheet, with a lot of cash and not much debt, this could be used for a number of different things but most likely will be used to increase their R&D.

Recs

0
Member Avatar kenc132000 (82.50) Submitted: 3/18/2009 11:39:33 AM : Outperform Start Price: $8.84 NYSE:MRX Score: +124.27

New 52 week low. Double down on losing position.

Leaderboard

Find the members with the highest scoring picks in MRX.

Score Leader

ksmack

ksmack (68.99) Score: +213.52

The Score Leader is the player with the highest score across all their picks in MRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
kenc132000 82.50 3/18/2009 Outperform 1Y $8.84 +397.35% +273.08% +124.27 1 Comment
akdag < 20 3/18/2009 Outperform 3W $8.89 +394.66% +272.70% +121.97 0 Comment
simplylearning 39.70 1/9/2007 Underperform 3M $36.49 +20.53% +113.81% +93.28 0 Comment
sanidj < 20 11/29/2006 Underperform 1Y $35.48 +23.96% +116.51% +92.55 0 Comment
kingofprofit 46.88 10/6/2008 Outperform 1Y $12.15 +262.07% +172.56% +89.51 0 Comment
GoldDontGlitter 95.33 12/8/2009 Underperform 5Y $23.76 +85.10% +158.69% +73.59 0 Comment
PurePwnage 99.13 11/27/2009 Underperform 5Y $23.02 +91.05% +162.60% +71.56 0 Comment
ugurmidtown 81.73 10/16/2008 Outperform NS $11.06 +297.67% +226.27% +71.40 0 Comment
mddmk 63.27 10/29/2008 Outperform 1Y $11.69 +276.08% +206.24% +69.83 0 Comment
jfillon 31.45 9/30/2008 Outperform 1Y $13.48 +226.38% +156.76% +69.62 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackGoldmanSach 76.70 5/25/2012 Outperform NS $36.32 +21.10% +114.87% -93.77 0 Comment
TrackAurigaUSA 64.67 4/26/2012 Outperform NS $38.04 +15.62% +104.95% -89.33 0 Comment
TrackStifel 91.43 3/19/2012 Outperform NS $37.11 +18.50% +103.02% -84.52 0 Comment
TrackJimCramer 86.36 2/14/2011 Underperform 3W $27.49 +59.96% +113.34% +53.38 0 Comment
TrackJefferies 80.59 9/16/2010 Outperform NS $29.50 +49.06% +152.51% -103.45 0 Comment
TrackZacks < 20 8/11/2010 Outperform 3M $26.76 +2.77% -3.65% +6.42 8/31/2010 @ $27.50 1 Comment
TrackCanaccord 68.18 3/4/2010 Outperform NS $22.09 +47.40% +13.67% +33.73 1/9/2012 @ $32.56 0 Comment
TrackTWeisel 87.85 10/23/2009 Outperform NS $22.74 +93.41% +159.51% -66.10 0 Comment
TrackVanDenBerg 92.04 9/30/2009 Outperform NS $20.76 +111.84% +176.42% -64.58 0 Comment
TrackBernstein 89.67 4/29/2009 Outperform NS $12.83 +242.76% +232.51% +10.25 0 Comment
TrackPiperJaff 84.71 3/12/2009 Underperform NS $10.00 +145.01% +53.00% -92.01 11/17/2009 @ $24.49 0 Comment
TrackWellsFargo 87.98 2/5/2009 Outperform NS $11.41 +285.42% +250.30% +35.13 0 Comment
TrackJefferies 80.59 12/2/2008 Outperform NS $13.76 +2.70% +1.59% +1.10 1/30/2009 @ $14.13 0 Comment
TrackJGreenblatt 47.61 8/18/2008 Outperform 1Y $20.61 -18.63% -24.61% +5.99 8/17/2009 @ $16.77 2 Comments
TrackEveillard 91.27 9/30/2007 Outperform NS $29.14 +50.94% +95.47% -44.53 1 Comment
TrackMatrix < 20 9/14/2007 Underperform NS $28.86 +30.90% -6.68% -37.58 4/17/2012 @ $37.78 0 Comment
TrackJefferies 80.59 2/9/2007 Outperform NS $38.51 -39.47% -5.35% -34.12 1/16/2008 @ $23.31 0 Comment
TrackJPMorgan 84.99 11/8/2006 Outperform NS $37.98 -33.17% -13.76% -19.41 4/30/2010 @ $25.38 0 Comment
TrackDeutscheSec 80.83 10/12/2006 Outperform NS $34.03 +29.23% +122.92% -93.69 0 Comment
TrackCreditSuiss 88.13 10/5/2006 Outperform NS $33.89 -38.95% -4.98% -33.97 9/3/2008 @ $20.69 0 Comment
TrackRothCapital 62.47 9/29/2006 Outperform NS $31.00 -33.51% -20.13% -13.38 10/9/2009 @ $20.61 0 Comment
TrackRBCCapMkts 84.36 9/26/2006 Outperform NS $29.14 +50.94% +128.06% -77.12 0 Comment
TrackJimCramer 86.36 3/20/2006 Outperform 3W $30.42 -8.05% +2.31% -10.35 2/15/2011 @ $27.97 0 Comment